Amoxicillin + Clavulanic Acid Suppliers & Bulk Manufacturers
Available Forms: Tablets, Oral suspension, Sachets and Chewables
Available Strengths: All Forms in US: 250/125 mg to 1000/62.5 mg; For EU: 250/125 mg to 1000/125 mg
Reference Brands: Clavulin®, Augmentin®(Eu & US)
Category:
Respiratory Disorder
Amoxicillin + Clavulanic Acid (Co-amoxiclav) is a broad-spectrum antibiotic used for respiratory and other infections. Available in the US and EU as tablets, chewables, and suspensions under brands like Augmentin®, it offers strong bacterial coverage and is ideal for B2B, PCD, and global pharma markets.
Amoxicillin + Clavulanic Acid is available in Tablets, Oral suspension, Sachets and Chewables
and strengths such as All Forms in US: 250/125 mg to 1000/62.5 mg; For EU: 250/125 mg to 1000/125 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Amoxicillin + Clavulanic Acid is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Amoxicillin + Clavulanic Acid can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Amoxicillin + Clavulanic Acid, also known as co-amoxiclav, is a powerful broad-spectrum antibiotic combination used to treat respiratory infections, sinusitis, otitis media, and skin infections. Available in the US and EU under brands like Augmentin®, Clavulin®, and generics, it comes in tablets (250/125 mg to 1000/125 mg), chewables, and oral suspensions (125/31.25 mg to 600/42.9 mg per 5 mL). This combination enhances bacterial resistance coverage and is widely prescribed for both adults and children. Highly in demand for B2B, PCD, and global export markets, co-amoxiclav is a staple in respiratory and general infection treatment protocols worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing